Principal Engineer, Algorithm - ECG
Danaher Corporation
Summary
The Principal Engineer, Algorithm – ECG is responsible for the architecture, development, and advancement of ECG signal processing algorithms that support accurate and reliable cardiac monitoring across Masimo’s non-invasive platforms. This role provides technical and project leadership for the innovation in ECG-based measurements, including heart rate, rhythm analysis, and advanced cardiac insights, translating complex physiological signals into clinically meaningful outputs. This role collaborates closely with cross-functional teams spanning hardware, software, systems, and clinical disciplines to develop high-performance, regulatory-compliant solutions from concept through commercialization. The position reports to the Manager, Algorithm – ECG and is part of the R&D Algorithm Engineering department located in Irvine, CA and will be an on-site role.
Job description
In This Role, You Will Have The Opportunity To:
- Lead the design and development of advanced ECG signal processing algorithms, including filtering, feature extraction, waveform delineation, and rhythm classification.
- Architect scalable algorithm frameworks for ECG analysis, supporting real-time embedded implementation and cloud-based analytics where applicable.
- Develop and optimize algorithms for heart rate detection, arrhythmia identification, and ECG morphology analysis.
- Design and conduct validation strategies using clinical datasets to ensure algorithm accuracy, robustness, and generalizability across diverse patient populations.
- Translate clinical and regulatory requirements into algorithm design inputs, ensuring compliance with applicable standards (e.g., FDA, IEC).
The Essential Requirements Of The Job Include:
- B.S. Degree in Electrical Engineering, Biomedical Engineering, Computer Engineering, or a related field.
- 12+ years of relevant experience in ECG algorithm development, signal processing, or related domain.
- Deep expertise in ECG signal processing, digital signal processing, and statistical modeling.
- Proven experience developing ECG algorithms, including waveform detection and cardiac feature extraction.
- Strong programming skills in C/C++, MATLAB, Python, or similar.
- Experience working with large-scale physiological or clinical datasets.
It would be a plus if you also possess previous experience in:
- Master’s or Ph.D. in Electrical Engineering, Biomedical Engineering, Computer Engineering, or a related field.
- Experience with arrhythmia detection/classification algorithms or cardiac monitoring systems.
- Knowledge of cardiac physiology and electrophysiology principles.
- Experience applying machine learning techniques to ECG or time-series physiological data.
- Familiarity with wearable or ambulatory ECG systems and associated signal challenges.
Requirements
- B.S. Degree in Electrical Engineering, Biomedical Engineering, Computer Engineering, or a related field.
- 12+ years of relevant experience in ECG algorithm development, signal processing, or related domain.
- Deep expertise in ECG signal processing, digital signal processing, and statistical modeling.
- Proven experience developing ECG algorithms, including waveform detection and cardiac feature extraction.
- Strong programming skills in C/C++, MATLAB, Python, or similar.
- Experience working with large-scale physiological or clinical datasets.
- Master’s or Ph.D. in Electrical Engineering, Biomedical Engineering, Computer Engineering, or a related field.
- Experience with arrhythmia detection/classification algorithms or cardiac monitoring systems.
- Knowledge of cardiac physiology and electrophysiology principles.
- Experience applying machine learning techniques to ECG or time-series physiological data.
- Familiarity with wearable or ambulatory ECG systems and associated signal challenges.
Benefits
- Health insurance
- Dental insurance
- Vision insurance
- 401(k)
- Paid time off
- Annual bonus up to 15%
Company overview
Danaher Corporation is a leading global science and technology innovator headquartered in Washington, D.C., specializing in biotechnology, life sciences, and diagnostics. Founded in 1984 by brothers Steven and Mitchell Rales, the company has evolved from its origins as a manufacturing conglomerate into a premier healthcare technology organization with approximately 63,000 employees worldwide. Danaher operates through three core divisions: biotechnology (28% of revenues), which develops products for therapeutic development; life sciences (31% of revenues), focused on disease identification, new therapies, and drug testing/manufacturing; and diagnostics (41% of revenues), providing instruments, consumables, and software for disease diagnosis. The company's portfolio includes renowned brands such as Beckman Coulter, Cytiva, Pall Corporation, Cepheid, Leica Microsystems, and Abcam, serving pharmaceutical companies, biotechnology firms, healthcare providers, and research institutions globally. Danaher is distinguished by its Danaher Business System (DBS), a continuous improvement methodology that drives innovation and operational excellence. With 2024 revenues of $23.9 billion, the company ranks 180th on the Fortune 500 and plays a critical role in advancing scientific research, improving diagnostic capabilities, and accelerating the development of life-saving therapies.